Range of suitable clients: CDEC reviewed the uncertainty in the volume of people with reasonably significant to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some sufferers who're classified as getting moderate or rea… Read More